Use and effects of cardiac rehabilitation in patients with coronary heart disease: Results from the EUROASPIRE III survey

European Journal of Preventive Cardiology

Volumn 20, Issue 5, 2013, Pages 817-826

  Kotseva, Kornelia ^a   Wood, David ^a   De Backer, Guy ^b   De Bacquer, Dirk ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

attendance; cardiac rehabilitation; cardiovascular prevention; coronary patients; EUROASPIRE III; risk factor management

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; EUROPE; FEMALE; HEALTH CARE SURVEY; HEART REHABILITATION; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREVALENCE; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; RISK FACTOR; SMOKING;

ATTENDANCE; CARDIAC REHABILITATION; CARDIOVASCULAR PREVENTION; CORONARY PATIENTS; EUROASPIRE III; RISK FACTOR MANAGEMENT;

AGED; CARDIOVASCULAR AGENTS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; HEALTH CARE SURVEYS; HUMANS; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; REFERRAL AND CONSULTATION; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84884136924     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/2047487312449591     Document Type: Review

References (24)

1. Graham I, Atar D, Borch-Johnsen K, et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007 ; 14 (Suppl 2). S1 - S113
2. Needs and priorities in cardiac rehabilitation and secondary prevention in patients with coronary heart disease. WHO Technical Report Series 831. Geneva: World Health Organisation, 1993.
3. Antman EM, Anbe ST, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2004 ; 44: 671-719
4. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2002 ; 40: 1366-1374
5. Gibbons RJ, Abrams J, Chatterjee K, et al ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2003; 107: 149-158.
6. Balady GJ, Williams M, Ades PA, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update. A Scientific Statement From the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2007 ; 115: 2675-2682
7. Giannuzzi P, Saner H, Björnstad H, et al. Secondary prevention through cardiac rehabilitation: position paper of the working group on cardiac rehabilitation and exercise physiology of the European society of Cardiology. Eur Heart J. 2003 ; 24: 1273-1278
8. Piepoli MF, Corra U, Benzer W, et al. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010 ; 17: 1-17
9. Papadakis S, Oldridge NB, Coyle D, et al. Economic evaluation of cardiac rehabilitation: a systematic review. Eur J Cardiovasc Prev Rehabil. 2005 ; 12: 513-520
10. Papadakis S, Reid RD, Coyle D, et al. Cost-effectiveness of cardiac rehabilitation program delivery models in patients at varying cardiac risk, reason for referral, and sex. Eur J Cardiovasc Prev Rehabil. 2008 ; 15: 347-353
11. Kotseva K, Wood D, De Backer G, et al, on behalf of EUROASPIRE Study Group Cardiovascular prevention guidelines - the clinical reality: a comparison of EUROASPIRE I, II and III surveys in 8 European countries. Lancet 2009; 372: 929-940.
12. Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from twenty-two European countries. Eur J Cardiovasc Prev Rehabil. 2009 ; 16: 121-137
13. The SAS system. Release 9.1.3, Cary, North Carolina: SAS Institute Inc.
14. Brown H, Prescott R Applied mixed models in medicine. 2 nd edn. New York: John Wiley & Sons, 2006. New York: John Wiley & Sons ; 2006 :
15. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004 ; 116: 782-792
16. Clark AM, Hartling L, Vandermeer B, et al. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med. 2005 ; 143: 659-672
17. McAlister FA, Lawson FME, Teo KK, et al. Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ. 2001 ; 323: 957-962
18. Kotseva K, Wood D, De Bacquer D, et al. Cardiac rehabilitation for coronary patients: lifestyle, risk factor and therapeutic management. Results from the EUROASPIRE II survey. Eur Heart J. 2004 ; 6 (Suppl J). J17 - J26
19. Cortes O, Arthur HM. Determinants of referral to cardiac rehabilitation programs in patients with coronary artery disease: a systematic review. Am Heart J. 2006 ; 151: 249-256
20. Daly J, Sindone AP, Thompson DR, et al. Barriers to participation in and adherence to cardiac rehabilitation programs: a critical literature review. Prog Cardiovasc Nurs. 2002 ; 17: 8-17
21. Cooper FA, Jackson G, Weinman J, et al. Factors associated with cardiac rehabilitation attendance: a systematic review of the literature. Clin Rehabil. 2002 ; 16: 541-541
22. Dunlay S, Witt B, Allison T, et al. Barriers to participation in cardiac rehabilitation. Am Heart J. 2009 ; 158: 852-859
23. Wood DA, Kotseva K, Connolly S, et al. EUROACTION: a European Society of Cardiology demonstration project in preventive cardiology. A paired cluster randomised controlled trial of a multi-disciplinary family based preventive cardiology programme for coronary patients and asymptomatic high risk individuals. Lancet. 2008 ; 371: 1999-2012
24. Giannuzzi P, Temporelli PL, Marchioli R, et al. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Arch Intern Med. 2008 ; 168: 2194-2204